These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14710890)

  • 1. The Sézary syndrome: hematologic criteria.
    Vonderheid EC; Bernengo MG
    Hematol Oncol Clin North Am; 2003 Dec; 17(6):1367-89, viii. PubMed ID: 14710890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome.
    Lima M; Almeida J; dos Anjos Teixeira M; Queiros ML; Santos AH; Fonseca S; Balanzategui A; Justica B; Orfao A
    Haematologica; 2003 Aug; 88(8):874-87. PubMed ID: 12935975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sézary syndrome: diagnostic criteria and therapeutic options.
    Russell-Jones R; Whittaker S
    Semin Cutan Med Surg; 2000 Jun; 19(2):100-8. PubMed ID: 10892711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating and skin-derived Sézary cells: clonal but with phenotypic plasticity.
    Roelens M; Delord M; Ram-Wolff C; Marie-Cardine A; Alberdi A; Maki G; Homyrda L; Bensussan A; Bagot M; Toubert A; Moins-Teisserenc H
    Blood; 2017 Sep; 130(12):1468-1471. PubMed ID: 28760889
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunopathogenesis of cutaneous T-cell lymphomas.
    Bagot M; Boumsell L; Bensussan A
    Hematol Oncol Clin North Am; 2003 Dec; 17(6):1313-7, vii. PubMed ID: 14710886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD164 on Malignant T cells in Sézary Syndrome.
    Guenova E; Ignatova D; Chang YT; Contassot E; Mehra T; Saulite I; Navarini AA; Mitev V; Dummer R; Kazakov DV; French LE; Hoetzenecker W; Cozzio A
    Acta Derm Venereol; 2016 May; 96(4):464-7. PubMed ID: 26524186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peripheral blood Sézary cells and the diagnosis of Sézary syndrome].
    Tessier-Marteau A; Le Corre Y; Gérard J; Avenel-Audran M; Geneviève F; Verret JL; Zandecki M
    Ann Biol Clin (Paris); 2008; 66(4):447-53. PubMed ID: 18725348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sézary syndrome without erythroderma: A review of 16 cases at Mayo Clinic.
    Thompson AK; Killian JM; Weaver AL; Pittelkow MR; Davis MD
    J Am Acad Dermatol; 2017 Apr; 76(4):683-688. PubMed ID: 28012574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of Sézary syndrome in a patient with generalized pruritus based on early molecular study and flow cytometry.
    Bowen GM; Stevens SR; Dubin HV; Siddiqui J; Cooper KD
    J Am Acad Dermatol; 1995 Oct; 33(4):678-80. PubMed ID: 7673506
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses.
    Harmon CB; Witzig TE; Katzmann JA; Pittelkow MR
    J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):404-10. PubMed ID: 8784277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sézary cell counts in erythrodermic cutaneous T-cell lymphoma: implications for prognosis and staging.
    Vonderheid EC; Pena J; Nowell P
    Leuk Lymphoma; 2006 Sep; 47(9):1841-56. PubMed ID: 17064997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of bullous Sézary syndrome.
    Ono A; Isomura I; Isogai Z; Shintani Y; Suzuki A; Morita A
    J Dermatol; 2004 Dec; 31(12):1027-31. PubMed ID: 15801270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells.
    Bernengo MG; Novelli M; Quaglino P; Lisa F; De Matteis A; Savoia P; Cappello N; Fierro MT
    Br J Dermatol; 2001 Jan; 144(1):125-35. PubMed ID: 11167693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Sézary cells. A new preparatory method for their identification and enumeration.
    Fletcher V; Zackheim HS; Beckstead JH
    Arch Pathol Lab Med; 1984 Dec; 108(12):954-8. PubMed ID: 6239604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonerythrodermic Sézary syndrome.
    Iqbal K; Bott J; Robson A; Post R; Morris S; Scarisbrick J
    Clin Exp Dermatol; 2011 Mar; 36(2):207-8. PubMed ID: 20659115
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythroderma is not all psoriasis: a case of Sézary syndrome.
    Dubrey SW; Rosser G; Patel K; Whittaker SJ
    Br J Hosp Med (Lond); 2014 Jan; 75(1):50-1. PubMed ID: 24401973
    [No Abstract]   [Full Text] [Related]  

  • 17. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
    Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
    Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotypic identification of Sezary cells in peripheral blood.
    Bogen SA; Pelley D; Charif M; McCusker M; Koh H; Foss F; Garifallou M; Arkin C; Zucker-Franklin D
    Am J Clin Pathol; 1996 Dec; 106(6):739-48. PubMed ID: 8980349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood sCD3⁻ CD4⁺ T cells: a useful diagnostic tool in angioimmunoblastic T cell lymphoma.
    Singh A; Schabath R; Ratei R; Stroux A; Klemke CD; Nebe T; Flörcken A; van Lessen A; Anagnostopoulos I; Dörken B; Ludwig WD; Pezzutto A; Westermann J
    Hematol Oncol; 2014 Mar; 32(1):16-21. PubMed ID: 23798351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A realistic approach to the sensitivity of PCR-DGGE and its application as a sensitive tool for the detection of clonality in cutaneous T-cell proliferations.
    Meyer JC; Hassam S; Dummer R; Muletta S; Döbbeling U; Dommann SN; Burg G
    Exp Dermatol; 1997 Jun; 6(3):122-7. PubMed ID: 9226134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.